Larvol Delta - A-Prospective-Comparative-Study-Of-Three-Different-Induction-Agents-In-ABO-Incompatible-Renal-Transplantation-From-a-Tertiary-Care-Centre-In-India

Rituxan (rituximab) - Roche

Simulect (basiliximab) - Novartis

https://app.tts2026.org/program_view/presentation/1895

Amar Jha1; Pratik Das1

Sep 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next